tirofiban has been researched along with Death, Sudden, Cardiac in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dambrink, JH; de Boer, MJ; de Vries, ST; Gosselink, AT; Hoorntje, JC; Miedema, K; Suryapranata, H; van 't Hof, AW; Zijlstra, F | 1 |
| Eberli, FR; Hess, OM; Locher, S; Meier, B; Remondino, A; Rey, C; Seiler, C; Togni, M; Tüller, D; Wenaweser, P; Windecker, S | 1 |
1 trial(s) available for tirofiban and Death, Sudden, Cardiac
| Article | Year |
|---|---|
A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study. 2b/3a upstream therapy and acute coronary syndromes.
Topics: Angina, Unstable; Coronary Angiography; Death, Sudden, Cardiac; Female; Humans; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Time Factors; Tirofiban; Treatment Outcome; Tyrosine | 2003 |
1 other study(ies) available for tirofiban and Death, Sudden, Cardiac
| Article | Year |
|---|---|
Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Blood Vessel Prosthesis; Death, Sudden, Cardiac; Emergency Treatment; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Platelet Aggregation Inhibitors; Secondary Prevention; Stents; Survival Analysis; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine | 2005 |